AI assistant
CYTOKINETICS INC — Director's Dealing 2023
Mar 7, 2023
30870_dirs_2023-03-07_8e598542-c894-4ecf-8b30-d5c667a83de1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2023-03-06
Reporting Person: Blum Robert I (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-06 | Common Stock | M | 12500 | $9.65 | Acquired | 382958 | Direct |
| 2023-03-06 | Common Stock | S | 12500 | $39.94 | Disposed | 370458 | Direct |
| 2023-03-06 | Common Stock | F | 11900 | $39.13 | Disposed | 358558 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-03-06 | Non-Qualified Stock Option (Right to Buy) | $9.65 | M | 12500 | Disposed | 2024-02-24 | Common Stock (12500) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2083 | Indirect |
| Common Stock | 2083 | Indirect |
Footnotes
F1: Shares held by The Bridget Blum 2003 Irrevocable Trust.
F2: Shares held by The Brittany Blum 2003 Irrevocable Trust.
F3: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on December 27, 2022.
F4: The reporting person is reporting the withholding of shares of common stock to satisfy the reporting persons withholding obligations in connection with the vesting of Restricted Stock Units vested on March 6, 2023 and does not represent a sale by the reporting person.